Therapeutic options for the 2019 novel coronavirus (2019-nCoV)
G Li, E De Clercq - Nature reviews Drug discovery, 2020 - nature.com
Therapeutic options for the 2019 novel coronavirus (2019-nCoV) Skip to main content Thank
you for visiting nature.com. You are using a browser version with limited support for CSS. To …
you for visiting nature.com. You are using a browser version with limited support for CSS. To …
Host-directed antiviral therapy
Antiviral drugs have traditionally been developed by directly targeting essential viral
components. However, this strategy often fails due to the rapid generation of drug-resistant …
components. However, this strategy often fails due to the rapid generation of drug-resistant …
Overview of recent strategic advances in medicinal chemistry
G Wu, T Zhao, D Kang, J Zhang, Y Song… - Journal of medicinal …, 2019 - ACS Publications
Introducing novel strategies, concepts, and technologies that speed up drug discovery and
the drug development cycle is of great importance both in the highly competitive …
the drug development cycle is of great importance both in the highly competitive …
Molecular docking and dynamics studies of Nicotinamide Riboside as a potential multi-target nutraceutical against SARS-CoV-2 entry, replication, and transcription: A …
Z Esam, M Akhavan, A Bekhradnia - Journal of molecular structure, 2022 - Elsevier
Abstract The highly contagious Coronavirus Disease 2019 (COVID-19) caused by Severe
Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), which is a newborn infectious …
Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), which is a newborn infectious …
Inhibitors of nucleotide biosynthesis as candidates for a wide spectrum of antiviral chemotherapy
CS Sepúlveda, CC García, EB Damonte - Microorganisms, 2022 - mdpi.com
Emerging and re-emerging viruses have been a challenge in public health in recent
decades. Host-targeted antivirals (HTA) directed at cellular molecules or pathways involved …
decades. Host-targeted antivirals (HTA) directed at cellular molecules or pathways involved …
Recent advances on heterocyclic compounds with antiviral properties
In recent years several important viral infections have emerged and antiviral
chemotherapeutic agents are not sufficiently effective in clinic, leading to serious human …
chemotherapeutic agents are not sufficiently effective in clinic, leading to serious human …
N-Heterocycles as Promising Antiviral Agents: A Comprehensive Overview
Viruses are a real threat to every organism at any stage of life leading to extensive infections
and casualties. N-heterocycles can affect the viral life cycle at many points, including viral …
and casualties. N-heterocycles can affect the viral life cycle at many points, including viral …
[PDF][PDF] Inhibitors of Nucleotide Biosynthesis as Candidates for a Wide Spectrum of Antiviral Chemotherapy. Microorganisms 2022, 10, 1631
CS Sepúlveda, CC García, EB Damonte - 2022 - academia.edu
Emerging and re-emerging viruses have been a challenge in public health in recent
decades. Host-targeted antivirals (HTA) directed at cellular molecules or pathways involved …
decades. Host-targeted antivirals (HTA) directed at cellular molecules or pathways involved …
Sistematični pregled in napoved toksičnosti potencialnih učinkovin za zdravljenje COVID-19
M Bajželj - 2020 - repozitorij.uni-lj.si
Abstract Koronavirusno bolezen 2019 (COVID-19) povzroča koronavirus SARS-CoV-2, virus
RNA z ovojnico. Zaradi hitrega širjenja nalezljive bolezni na vseh celinah je Svetovna …
RNA z ovojnico. Zaradi hitrega širjenja nalezljive bolezni na vseh celinah je Svetovna …
[PDF][PDF] Overview of Recent Strategic Advances in Medicinal Chemistry
OM Denmark - 2019 - researchgate.net
Introducing novel strategies, concepts and technologies that speed up drug discovery and
the drug development cycle is of great importance both in the highly competitive …
the drug development cycle is of great importance both in the highly competitive …